Journal profile · Biochemistry, Genetics and Molecular Biology-Biotechnology
Avicenna Journal of Medical Biotechnology
ISSN 2008-2835 · eISSN 2008-4625 · Avicenna Research Institute
Avicenna Journal of Medical Biotechnology: subscription journal; APC charged, amount not published; median 114 days to acceptance (52 articles, last 24 months); 38 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Avicenna Journal of Medical Biotechnology is published by Avicenna Research Institute. By OpenAlex counts of its recent articles, its largest topics are Monoclonal and Polyclonal Antibodies Research, Nanoparticles: synthesis and applications and SARS-CoV-2 and COVID-19 Research, together about 22.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Avicenna Journal of Medical Biotechnology (AJMB) is the official journal of Avicenna Research Institute (ARI). AJMB is a peer-reviewed Journal, provides a scientific medium of communication for researchers in the field of Medical Biotechnology, and publishes the articles on all aspects of medical biotechnology which may include: New Products Nucleic Acids Gene therapy Molecular Biology Nanobiotechnology Bioinformatics Biodiagnostics Biochemistry Biochemical Engineering Bioprocess Engineering Transgenic therapeutics Biotherapeutics Industrial Processes Clinical trial reports Bioethics and Biopharmaceuticals
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Biotechnology
Editor-in-chief Shahin AkhondzadehPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Monoclonal and Polyclonal Antibodies ResearchMedicine7.7%
- Nanoparticles: synthesis and applicationsMaterials Science7.3%
- SARS-CoV-2 and COVID-19 ResearchMedicine7.3%
- Mesenchymal stem cell researchMedicine7.3%
- Medicinal Plant ResearchAgricultural and Biological Sciences6.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.8%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology4.4%
- Wound Healing and TreatmentsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Biotechnology | Q3 | 205/325 | 37th |
| Applied Microbiology and Biotechnology | Q3 | 86/134 | 36th |
| Biomedical Engineering | Q3 | 219/342 | 36th |
| Bioengineering | Q4 | 131/168 | 22nd |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.8LetPub ·
- SJR 2026-06
- 0.45LetPub ·
- SNIP 2026-06
- 0.51LetPub ·
- h-index
- 13OpenAlex ·
- i10-index
- 23OpenAlex ·
- 2-year mean citedness
- 1.14OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 231 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 27 | 121 |
| 2025 | 38 | 38 | 225 |
| 2024 | 27 | 27 | 208 |
| 2023 | 37 | 37 | 148 |
| 2022 | 52 | 51 | 80 |
| 2021 | 30 | 30 | 18 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
114 daysMedian, submission to acceptance · P25–P75 85 days – 150 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 52 articles with submission and acceptance dates (65 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Other fees
- No other fees
- Page charges
- No page charges
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Manuscript length
- ≤ 4,500 words
- Suggested reviewers
- Optional, 5
- Cover letter
- Required
Article types accepted12, with length limits
- brief /short communicationsBrief /Short Communications: AJMB also encourages the authors to submit brief communications as they are used to report findings that are not suitable for a ful…Length not stated
- case reportarrative reviews described above apply. Case reports: Case reports should be limited to 1500 words excluding the references. They should include abstract notmain text ≤ 1,500 words
- case reportsCase reports: Case reports should be limited to 1500 words excluding the references.Length not stated
- clinical trial reportsClinical trial reportsLength not stated
- letters to the editorLetters to the Editor: A Letter to the Editor is a brief communication to a journal’s editor or editorial team.Length not stated
- mini reviewsMini reviews: The aim of mini-reviews in medical sciences is to publish short reviews on the important recent developments in medicine and relevant disciplines.Length not stated
- narrative review, figures, and legends should be added. Narrative reviews should not exceed 5000 words excluding the references. Systemic reviews with logical metmain text ≤ 5,000 words
- original researchOriginal Research: The most common type of journal manuscripts received by the journal office are full reports of data from research. It may be called an Origin…Length not stated
- reviewmedicine and relevant disciplines. Mini-reviews should not exceed 1500 words. The same conditions as narrative reviews described above amain text ≤ 1,500 words
- review articleReview ArticleLength not stated
- review articlesReview articles: Review papers are high ranked scholarly manuscripts written by experts who not only are aware of the research and technical developments in the…Length not stated
- systematic reviewigures, and legends should be inserted. Systematic reviews should not exceed 5000 words excluding the references. Moreover, systematic review shoulmain text ≤ 5,000 words
Policy excerpts from the journal's websiteConflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- Conflicts of interest Conflict of Interest
Provide a notification regarding potential conflict (s) of interest for authors. If this is not the case, state its absence.
Source ↗Publisher website ·- Publication ethics
Follows ICMJE and COPE standards. Model summary
AJMB is committed to follow and apply International Committee of Medical Journal Editors (ICMJE) and International Standards for Authors and Editors of Committee on Publication Ethics in designing and leading the Journal’s reviewing and publishing process and dealing with its issues. It also follows Principles of transparency and best practice for scholarly publications based on COPE guideline.
Source ↗Publisher website ·- License & copyright Copyright Notice
CC BY-NC 4.0 license. Model summary
Authors have copyright but license exclusive rights in their article to the publisher *. Authors have the right to: Share their article according to the "Personal Use rights" ** so long as it contains the end user license and the DOI link to the version of record in this journal. Retain intellectual property rights (including research data). Proper attribution and credit for the published work. Th…
Source ↗Publisher website ·- Open access Open Access Policy
Immediate open access; all papers distributed under CC BY-NC 4.0. Model summary
Avicenna Journal of Medical Biotechnology (AJMB) provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. All journal papers are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, …
Source ↗Publisher website ·- Peer review
Double-blind peer review. Model summary
AJMB is committed to apply double-blind peer reviewing process, based on the ICMJE's Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and Principles of Transparency and Best Practice in Scholarly Publishing.
Source ↗Publisher website ·- Plagiarism
Plagiarism check by iThenticate at submission and before publication. Model summary
All submitted manuscripts in AJMB, undergo plagiarism check by Plagiarism Detection Software ithenticate twice: at the time of submission and before publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Avicenna Research Institute
- ISSN
- 2008-2835
- Electronic ISSN
- 2008-4625
- Society / sponsor
- Avicenna Research Institute
- Latest issue on the website
- Volume 18, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Avicenna Journal of Medical Biotechnology
How long does peer review take at Avicenna Journal of Medical Biotechnology?
Based on the dates recorded on 52 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 114 days (interquartile range 85–150 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Avicenna Journal of Medical Biotechnology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Manuscript length: ≤ 4,500 words; Suggested reviewers: Optional, 5; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Avicenna Journal of Medical Biotechnology?
According to LetPub and DOAJ records, Avicenna Journal of Medical Biotechnology is indexed in Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Avicenna Journal of Medical Biotechnology open access, and what is the APC?
Avicenna Journal of Medical Biotechnology is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .